Delivering Cures in a Decade: NephCure Partners with PNRC to Provide Grant Opportunities for Pediatric Glomerular Disease Research

KING OF PRUSSIA, PA (July 13, 2022) – NephCure Kidney International (NephCure), a nonprofit focused on finding better treatments for patients suffering from rare, protein-spilling kidney diseases, is proud to collaborate with the Pediatric Nephrology Renal Consortium (PNRC) to provide the Pediatric Glomerular Disease Accelerator Grant Program: Delivering Cures in a Decade.

The Delivering Cures in a Decade grant program will provide small and medium-sized grants to nephrologists and researchers studying pediatric glomerular diseases, beginning this year, and running through 2024. This program aims to fund and accelerate research that will provide insights and evidence to help cure pediatric glomerular disorders.

“The Pediatric Glomerular Disease Accelerator Grant Program is so exciting for our research community! Investigators in pediatric glomerular disorders are not short of innovative ideas and novel approaches to mechanisms of disease and potential therapeutics,” said John D. Mahan, MD, the PNRC Board President. “The gap that this grant program can really address is the current lack of critical seed funding to take these ideas from ‘concepts’ to ‘explored’, and as such lead to new treatments and cure.  We could not be more excited or more committed to this work.”

The NephCure and PNRC collaboration came from a mutual desire to promote and support areas of bench, translational, and clinical research in pediatric glomerular disease.

“We are very hopeful that the NephCure and PNRC Delivering Cures in a Decade grant will provide invaluable insights and lead to changes of how we care for children affected by rare, protein-spilling kidney diseases,” Josh Tarnoff, NephCure CEO, said.

This international grant program is open to any pediatric nephrologist or pediatric nephrology scientist. Applicants do not have to be a member of the PNRC to apply. The total award funds vary, from $10,000-$20,000 small awards to $50,000-$75,000 medium awards. Both NephCure and PNRC will review grant applications, and awardees will be announced in the fall at the PNRC members meetings.

To learn more about the Delivering Cures in a Decade grant program application guidelines, eligibility, deadlines, and review process, visit

About NephCure Kidney International

NephCure Kidney International’s mission is to accelerate research for effective treatments for rare forms of Nephrotic Syndrome, and to provide education and support that will improve the lives of those affected by these protein-spilling kidney diseases. Founded in 2000 by a group of committed patient parents, NephCure has invested more than $40 million in kidney disease research and helped create a landscape where there are now more than 40 interventional drug trials for primary glomerular kidney diseases. NephCure is a U.S. tax exempt 501(c)(3) public charity.



Sign up to get NephCure’s latest updates.

This field is for validation purposes and should be left unchanged.